Clinical trial
Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early…
NCT00374803 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00374803 |
|---|---|
| Title | Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal |
| Official title | A 12-month, Prospective, Randomized, Single Center, Open Label Pilot Study to Evaluate the Safety and Efficacy of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | End Stage Renal Disease (ESRD) |
| Intervention type | Drug |
| Interventions | Mycophenolic Acid (Myfortic) |
| Enrollment | 45 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 11, 2006 |
| Last update posted | Apr 28, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: